Medline Exits All Medline Brand Beds, Estimates Up To $220 Million In Costs
The affected beds made about $60 million in net sales over twelve months, and the company does not expect a material hit to 2026 results.
Medline is pulling every bed sold under its own brand and estimates costs of up to $220 million, according to an 8-K it filed Wednesday. The product line generated about $60 million in net sales in the twelve months ended June 27, 2026.
What the 8-K says
Medline began a voluntary field action on October 14 covering removal, discontinuation and market exit of all Medline Brand beds. That includes homecare, bariatric and long-term care beds, plus their pendants, accessories, replacement parts and order packages that contain a bed.
The beds sit in the Front Line Care category of the Medline Brand segment. The company expects the costs to cover inventory impairment, disposal and customer credits, to fall in 2026 and 2027, and to be left out of Adjusted EBITDA.
The filing calls it too early to know the total cost. The range reflects uncertainty over how many customers take part, and the company said actual customer credits may differ materially.
What it changes
Medline does not currently expect a material impact on its fiscal 2026 financial results, including the full-year guidance it gave on August 5, 2026. The estimated cost is far larger than the line's annual sales, but it is spread across two years and excluded from the adjusted measure.
The Rhode Island Department of Health published a notice on Tuesday about the removal. It said the removal also covers associated pendants, accessories, replacement parts and bed-containing order packages, and cited electrical safety risks and entrapment risk as the stated reasons.
Medline shares closed at $35.31 on Wednesday, down 0.42% from $35.46 the prior close, in a session that ended before the filing was accepted at 4:17 p.m. ET.
The size of the final bill depends on customer participation, which Medline said could move the costs materially across 2026 and 2027.
Sources
- 8-K Filing — Medline Inc. (MDLN) — SEC EDGAR
- Medline Beds Recalled | Department of Health — health.ri.gov